Arcus Biosciences, Inc. (RCUS)

bluebird bio Revenue

Arcus Biosciences had revenue of $28.00M in the quarter ending March 31, 2025, a decrease of -80.69%. This brings the company's revenue in the last twelve months to $141.00M, down -40.51% year-over-year. In the year 2024, Arcus Biosciences had annual revenue of $258.00M with 120.51% growth.

• Revenue (ttm): $141.00M
• Revenue Growth: -40.51%
• P/S Ratio: 6.05
• Revenue / Employee: $224,880
• Employees: 627
• Market Cap: 969.91M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	258.00M	141.00M	120.51%
Dec 31, 2023	117.00M	5.00M	4.46%
Dec 31, 2022	112.00M	-271.00M	-70.76%
Dec 31, 2021	383.00M	305.00M	391.03%
Dec 31, 2020	78.00M	63.00M	420.00%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.